High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease

This study has been terminated.

( Efforts at recruitment have halted as recruitment was poor. )

Study NCT00417690 Information provided by Jacobus Pharmaceutical

First Received: January 2, 2007 Last Updated: October 14, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Crohn's Disease

Additional conditions recognized in this trial

Crohn Disease
Enteritis
Ileitis

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

More general drug interventions related to this trial

Sponsors listed in this trial